{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:04:58Z","timestamp":1785150298484,"version":"3.55.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"15","license":[{"start":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T00:00:00Z","timestamp":1552089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,14]]},"DOI":"10.1093\/eurheartj\/ehz069","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T20:16:16Z","timestamp":1548965776000},"page":"1202-1210","source":"Crossref","is-referenced-by-count":43,"title":["Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry"],"prefix":"10.1093","volume":"40","author":[{"given":"Bjorn","family":"Redfors","sequence":"first","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital, Bruna str\u00e5ket 16, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Dworeck","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital, Bruna str\u00e5ket 16, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Haraldsson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital, Bruna str\u00e5ket 16, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Anger\u00e5s","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital, Bruna str\u00e5ket 16, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Odenstedt","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital, Bruna str\u00e5ket 16, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ioanes","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital, Bruna str\u00e5ket 16, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petur","family":"Petursson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital, Bruna str\u00e5ket 16, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"V\u00f6lz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital, Bruna str\u00e5ket 16, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Albertsson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital, Bruna str\u00e5ket 16, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truls","family":"R\u00e5munddal","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital, Bruna str\u00e5ket 16, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Persson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Danderyd University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Koul","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Erlinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmir","family":"Omerovic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital, Bruna str\u00e5ket 16, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,9]]},"reference":[{"key":"2019041404583157400_ehz069-B1","first-page":"e362","article-title":"American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"2019041404583157400_ehz069-B2","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"2019041404583157400_ehz069-B3","doi-asserted-by":"crossref","first-page":"e002301","DOI":"10.1161\/CIRCINTERVENTIONS.114.002301","article-title":"Pretreatment with antiplatelet drugs in invasively managed patients with coronary artery disease in the contemporary era: review of the evidence and practice guidelines","volume":"8","author":"Capodanno","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"2019041404583157400_ehz069-B4","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2019041404583157400_ehz069-B5","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2005.10.047","article-title":"Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention","volume":"47","author":"Steinhubl","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2019041404583157400_ehz069-B6","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"2019041404583157400_ehz069-B7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"2019041404583157400_ehz069-B8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00392-011-0393-1","article-title":"Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial","volume":"101","author":"Zeymer","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"2019041404583157400_ehz069-B9","doi-asserted-by":"crossref","first-page":"g6269.","DOI":"10.1136\/bmj.g6269","article-title":"Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis","volume":"349","author":"Bellemain-Appaix","year":"2014","journal-title":"BMJ"},{"key":"2019041404583157400_ehz069-B10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.294.10.1224","article-title":"Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study","volume":"294","author":"Sabatine","year":"2005","journal-title":"JAMA"},{"key":"2019041404583157400_ehz069-B11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4244\/EIJ-D-17-00852","article-title":"The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis","volume":"14","author":"Bellemain-Appaix","year":"2018","journal-title":"EuroIntervention"},{"key":"2019041404583157400_ehz069-B12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","article-title":"Prehospital ticagrelor in ST-segment elevation myocardial infarction","volume":"371","author":"Montalescot","year":"2014","journal-title":"N Engl J Med"},{"key":"2019041404583157400_ehz069-B13","first-page":"1535","article-title":"Prognostic impact of chronic total occlusions: a report from SCAAR (Swedish Coronary Angiography and Angioplasty Registry)","volume":"9","author":"Ramunddal","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2019041404583157400_ehz069-B14","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1308789","article-title":"Thrombus aspiration during ST-segment elevation myocardial infarction","volume":"369","author":"Frobert","year":"2013","journal-title":"N Engl J Med"},{"key":"2019041404583157400_ehz069-B15","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1093\/eurheartj\/ehw284","article-title":"Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry","volume":"37","author":"Sahlen","year":"2016","journal-title":"Eur Heart J"},{"key":"2019041404583157400_ehz069-B16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification","volume":"16","author":"van Buuren","year":"2007","journal-title":"Stat Methods Med Res"},{"key":"2019041404583157400_ehz069-B17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/eurheartj\/ehs217","article-title":"Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry","volume":"34","author":"Angeras","year":"2013","journal-title":"Eur Heart J"},{"key":"2019041404583157400_ehz069-B18","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/sim.3618","article-title":"Imputing missing covariate values for the Cox model","volume":"28","author":"White","year":"2009","journal-title":"Stat Med"},{"key":"2019041404583157400_ehz069-B19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","article-title":"Inference and missing data","volume":"63","author":"Rubin","year":"1976","journal-title":"Biometrika"},{"key":"2019041404583157400_ehz069-B20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.0006-341X.2000.00909.x","article-title":"Interpreting parameters in the logistic regression model with random effects","volume":"56","author":"Larsen","year":"2000","journal-title":"Biometrics"},{"key":"2019041404583157400_ehz069-B21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijcard.2015.04.135","article-title":"The ATLANTIC trial does not support the safety of prehospital ticagrelor treatment for patients with ST-elevation myocardial infarction","volume":"190","author":"Redfors","year":"2015","journal-title":"Int J Cardiol"},{"key":"2019041404583157400_ehz069-B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9149(96)00217-2","article-title":"Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction","volume":"78","author":"Anderson","year":"1996","journal-title":"Am J Cardiol"},{"key":"2019041404583157400_ehz069-B23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ahj.2008.03.018","article-title":"Spontaneous reperfusion in ST-elevation myocardial infarction: comparison of angiographic and electrocardiographic assessments","volume":"156","author":"Bainey","year":"2008","journal-title":"Am Heart J"},{"key":"2019041404583157400_ehz069-B24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrcardio.2017.18","article-title":"Antithrombotic therapy for patients with STEMI undergoing primary PCI","volume":"14","author":"Franchi","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2019041404583157400_ehz069-B25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ahj.2017.10.021","article-title":"Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: insights from the ATLANTIC study","volume":"196","author":"Bagai","year":"2018","journal-title":"Am Heart J"},{"key":"2019041404583157400_ehz069-B26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4244\/EIJ-D-16-00965","article-title":"Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial","volume":"13","author":"Fabris","year":"2017","journal-title":"EuroIntervention"},{"key":"2019041404583157400_ehz069-B27","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.jacc.2016.02.045","article-title":"Crushed prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary intervention: the CRUSH Study","volume":"67","author":"Rollini","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2019041404583157400_ehz069-B28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacc.2014.08.056","article-title":"Ticagrelor crushed tablets administration in STEMI patients","volume":"65","author":"Parodi","year":"2015","journal-title":". J Am Coll Cardiol"},{"key":"2019041404583157400_ehz069-B29","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic events","volume":"368","author":"Bhatt","year":"2013","journal-title":"N Engl J Med"},{"key":"2019041404583157400_ehz069-B30","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/eurheartj\/ehv498","article-title":"The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX","volume":"37","author":"Gutierrez","year":"2016","journal-title":"Eur Heart J"},{"key":"2019041404583157400_ehz069-B31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ahj.2013.09.022","article-title":"DETermination of the role of OXygen in suspected acute myocardial infarction trial","volume":"167","author":"Hofmann","year":"2014","journal-title":"Am Heart J"},{"key":"2019041404583157400_ehz069-B32","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1616540","article-title":"Instantaneous wave-free ratio versus fractional flow reserve to guide PCI","volume":"376","author":"Gotberg","year":"2017","journal-title":"N Engl J Med"},{"key":"2019041404583157400_ehz069-B33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ahj.2016.02.007","article-title":"Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial)","volume":"175","author":"Erlinge","year":"2016","journal-title":"Am Heart J"},{"key":"2019041404583157400_ehz069-B34","first-page":"3): 623","article-title":"Prehospital administration of P2Y12 inhibitors and early coronary reperfusion in primary PCI: an observational comparative study","volume":"114","author":"De Backer","year":"2015","journal-title":"Thromb Haemost"},{"key":"2019041404583157400_ehz069-B35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4244\/EIJ-D-17-00092","article-title":"Incidence and outcome of switching of oral platelet P2Y receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: the SCOPE registry","volume":"13","author":"De Luca","year":"2017","journal-title":"EuroIntervention"},{"key":"2019041404583157400_ehz069-B36","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMoa1706443","article-title":"Bivalirudin versus heparin monotherapy in myocardial infarction","volume":"377","author":"Erlinge","year":"2017","journal-title":"N Engl J Med"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/15\/1202\/28374082\/ehz069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,14]],"date-time":"2019-04-14T08:58:46Z","timestamp":1555232326000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/40\/15\/1202\/5372330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,9]]},"references-count":36,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2019,3,9]]},"published-print":{"date-parts":[[2019,4,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehz069","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4,14]]},"published":{"date-parts":[[2019,3,9]]}}}